Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs midazolam for suicidal ideation in suicide attempters
IRCT20211121053132N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in suicidal ideation comparing Ketamine arm with Midazolam arm (2 arms). Primary endpoint: Change in suicidal ideation. Started Jul 2025; status: completed.
02
Drugs
ketaminemidazolam
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on IRCT20211121053132N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211121053132N3.